Could a druggist presume insulin was sold under physician direction for the diabetes-treatment exemption?
Apply this to your situation
This page answers the general question as of 1964. Ask about yours and see what current California tax law says, with citations.
Plain-English summary
California said that, for practical purposes, insulin sold by a druggist would be presumed to be used under a physician's direction for diabetes treatment. That presumption brought the sale within the liberalized exemption described in the memorandum unless evidence showed otherwise.
Common questions
Was the presumption absolute?
No. Contrary evidence could defeat it.
What treatment did the memorandum concern?
Diabetes treatment with insulin.
Citations and references
- California Revenue and Taxation Code section 6369 — medicine exemption applied in the memorandum
- 1963 amendment to section 6369 — statutory change identified as liberalizing the exemption
Source
- Annotated Legal Opinions collection: https://cdtfa.ca.gov/taxes-and-fees/annotations-menu.htm
- Annotation page: https://cdtfa.ca.gov/lawguides/vol2/suta/425-0000-all.html
- Original supporting opinion: https://cdtfa.ca.gov/lawguides/annotations/425-0460.pdf
Original ruling text
State of California
Board of Equalization
Memorandum
To:
Santa Barbara – Auditing (LCF)
From:
Tax Counsel (EHS) – Headquarters
Subject:
Ruling 22, Sales of Insulin
425.0460
Date:
October 28, 1964
In answer to your memo of October 20, 1964, we believe that for practical purposes we should presume that when insulin is sold by a druggist it is sold for use under the direction or as directed by a physician, thus meeting the liberalized exemption made by the 1963 amendment to section 6369.
EHS:fb
What does the law say today, for your facts?
This ruling is from 1964. Ezel checks current California tax law against your situation and cites the authority it relies on.
Opens in Ezel Pro.
- Checks the law as it stands today, not only this page
- Cites every source it relies on, so you can verify it
- Chat, drafting and research in one workspace